Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 4/20 | 0.34 |
| ▸ | MMP9 | P14780 | 4/20 | 0.34 |
| ▸ | MMP3 | P08254 | 2/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP12 | P39900 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | MMP14 | P50281 | 2/20 | 0.34 |
| ▸ | MMP16 | P51512 | 2/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
| ▸ | PLAU | P00749 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.33 |
| ▸ | HTR3B | O95264 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL19639552 | 0.93 | TSHR (0.35) | LMNATSHRALOX5MMP2MMP9 | |
| Acetic Acid SCHEMBL19639567 | 0.89 | TSHR (0.37) | LMNATSHRALOX5IRAK4PDCD1 | |
| Oxalic Acid SCHEMBL19639580 | 0.89 | TSHR (0.37) | LMNAKDM4ETSHRALOX5MMP2 | |
| SCHEMBL19639527 | 0.89 | KMT2A (0.37) | LMNATSHRALOX5IRAK4PDCD1 | |
| SCHEMBL30500521 | 0.89 | KMT2A (0.37) | LMNATSHRALOX5IRAK4PDCD1 | |
| Methyl Alcohol SCHEMBL28857894 | 0.88 | KMT2A (0.36) | LMNATSHRALOX5IRAK4PDCD1 | |
| Fumaric Acid SCHEMBL19639547 | 0.85 | HCAR2 (0.41) | LMNAKDM4ETSHRALOX5IRAK4 | |
| Maleic Acid SCHEMBL19639577 | 0.85 | HCAR2 (0.41) | LMNAKDM4ETSHRALOX5IRAK4 | |
| Benzoic Acid SCHEMBL19639530 | 0.85 | TSHR (0.41) | LMNAKDM4ETSHRALOX5PDCD1 | |
| Sulfuric Acid SCHEMBL19639569 | 0.85 | ESR1 (0.36) | LMNAKDM4EMMP2MMP9MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170342026-A1 | ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED | Guangzhou Insighter Biotechnology Co., Ltd. (CN) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342026-A1 | ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED | SUCNR1, SORD, BPGM | LMNA 4339/4885HIF1A 368/4885KDM4E 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.